- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02888288
Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).
This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Moshi, Tanzania
- Kilimanjaro Christian Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Youth between the ages of 12 and 24 years of age, attending the Teen Club HIV clinic at Kilimanjaro Christian Medical Centre (KCMC) and/or Mawenzi Hospital and receiving ART
- if > or =l to 18 years, able to understand the project and provide written, informed consent
- if < 18 years, a parent or guardian must provide written permission and participant must be able to assent
- all adolescents must also commit to attending 10 weekly CBT (SYV) sessions and 2 individual sessions.
Exclusion Criteria:
- Active psychosis, developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mental Health Intervention
This arm was designed based on mental health needs of HIV-infected youth in Tanzania.
It incorporates principles of cognitive behavioral therapy, interpersonal psychotherapy, and motivational interviewing built into 10 group sessions, approximately 90 minutes each (2 sessions with caregiver participation) and 2 individual sessions.
Groups are age and gender matched and facilitated by lay counselors with a mix of lived experience and prior mental health research experience.
|
Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game.
First session is a joint session with youth and caregivers.
Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV.
ART adherence is woven into case examples and discussions.
|
|
Active Comparator: Standard of Care
This arm includes standard medical care and adherence counseling with routine education prior to the start of the HIV youth clinic from which participants are recruited.
|
Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant attendance
Time Frame: weekly for 16 weeks during each intervention wave (over 2 years)
|
Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.
|
weekly for 16 weeks during each intervention wave (over 2 years)
|
|
Caregiver participation as measured by questionnaire
Time Frame: during 2 caregiver sessions
|
Record willingness of caregivers to participate (if unwilling, why not) and attendance.
|
during 2 caregiver sessions
|
|
Caregiver participation as measured by attendance sheet
Time Frame: during 2 caregiver sessions
|
during 2 caregiver sessions
|
|
|
Fidelity as measured by weekly supervisor meeting
Time Frame: weekly for 16 weeks during the intervention wave (over 2 years)
|
weekly for 16 weeks during the intervention wave (over 2 years)
|
|
|
Fidelity as measured by fidelity checklists
Time Frame: weekly for 16 weeks during the intervention wave (over 2 years)
|
weekly for 16 weeks during the intervention wave (over 2 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Change in ART adherence
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Compare the change in self-report adherence between the intervention group versus SOC.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Change in virologic outcomes
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Describe the proportion of youth with viral suppression (HIV-1 RNA < 400 copies/ml) in the intervention group and SOC.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Compare method of adherence measurement
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
Compare self-report ART adherence with drug level concentration of hair samples.
|
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
|
|
Change in mental health (individual)
Time Frame: baseline to post-intervention, 6-, 12-,18- and 24-months
|
Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.
|
baseline to post-intervention, 6-, 12-,18- and 24-months
|
|
Change in adherence (individual)
Time Frame: baseline to post-intervention, 6-, 12-, and 24-months
|
Compare the change in self-reported adherence and antiretroviral drug concentration in hair.
|
baseline to post-intervention, 6-, 12-, and 24-months
|
|
Change in HIV viral load (individual)
Time Frame: baseline to post-intervention, 6-, 12-, and 24-months
|
Compare the change in HIV viral load.
|
baseline to post-intervention, 6-, 12-, and 24-months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dorothy E Dow, MD, MSc-GH, Duke University
Publications and helpful links
General Publications
- Dow DE, Turner EL, Shayo AM, Mmbaga B, Cunningham CK, O'Donnell K. Evaluating mental health difficulties and associated outcomes among HIV-positive adolescents in Tanzania. AIDS Care. 2016 Jul;28(7):825-33. doi: 10.1080/09540121.2016.1139043. Epub 2016 Feb 3.
- Ramaiya MK, Sullivan KA, O' Donnell K, Cunningham CK, Shayo AM, Mmbaga BT, Dow DE. A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania. PLoS One. 2016 Nov 16;11(11):e0165936. doi: 10.1371/journal.pone.0165936. eCollection 2016.
- Gichane MW, Sullivan KA, Shayo AM, Mmbaga BT, O' Donnell K, Cunningham CK, Dow DE. Caregiver role in HIV medication adherence among HIV-infected orphans in Tanzania. AIDS Care. 2018 Jun;30(6):701-705. doi: 10.1080/09540121.2017.1391986. Epub 2017 Oct 23.
- Dow DE, Mmbaga BT, Gallis JA, Turner EL, Gandhi M, Cunningham CK, O'Donnell KE. A group-based mental health intervention for young people living with HIV in Tanzania: results of a pilot individually randomized group treatment trial. BMC Public Health. 2020 Sep 4;20(1):1358. doi: 10.1186/s12889-020-09380-3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00069892
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
Clinical Trials on Mental Health Intervention
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
National University of MalaysiaNot yet recruitingResilience | Depression - Major Depressive DisorderMalaysia
-
Fatima Jinnah Women UniversityCompletedPsychological DistressPakistan
-
40FYThe Ministry of SMEs and Startups. South KoreaCompletedPersonality | Mental Health ServicesKorea, Republic of
-
VA Office of Research and DevelopmentCompletedSubstance-Related Disorders | Depression | Stress Disorders, Post-Traumatic | AnxietyUnited States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)RecruitingDepressive Symptoms, Generalized Anxiety, or Psychological StressThailand
-
Universidad Internacional de ValenciaUniversidad Autonoma de Ciudad Juarez; Universidad Nacional Autonoma de MexicoCompletedDepression | Anxiety | Sleep DisturbanceMexico
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Ontario Ministry of Health and...CompletedDepressive SymptomsCanada
-
University of CoimbraNot yet recruitingChronic Pain | Mental Health | Health LiteracyPortugal
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)Not yet recruitingPerinatal Depression | Anxiety Sensitivity | Perinatal Anxiety